Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Familial Cancer|April 5, 2008
Mutation spectrum in HNPCC in the Israeli populationYael Goldberg, Rinnat M Porat, Inbal Kedar, et al.
The Journal of Investigative Dermatology|December 1, 2007
KRT14 haploinsufficiency results in increased susceptibility of keratinocytes to TNF-alpha-induced apoptosis and causes Naegeli-Franceschetti-Jadassohn syndromeJennie Lugassy, John A McGrath, Peter Itin, et al.
Familial Cancer|October 24, 2009
An Ashkenazi founder mutation in the MSH6 gene leading to HNPCCYael Goldberg, Rinnat M Porat, Inbal Kedar, et al.
American Journal of Medical Genetics. Part A|September 25, 2004
A mixed epigenetic/genetic model for oligogenic inheritance of autism with a limited role for UBE3AYong-Hui Jiang, Trilochan Sahoo, Ron C Michaelis, et al.
American Journal of Human Genetics|June 22, 2005
A mutation in SNAP29, coding for a SNARE protein involved in intracellular trafficking, causes a novel neurocutaneous syndrome characterized by cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratodermaEli Sprecher, Akemi Ishida-Yamamoto, Mordechai Mizrahi-Koren, et al.
The Journal of Experimental Medicine|May 4, 2011
Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemiasChen Shochat, Noa Tal, Obul R Bandapalli, et al.
Blood|May 31, 2012
Cell lineage analysis of acute leukemia relapse uncovers the role of replication-rate heterogeneity and microsatellite instabilityLiran I Shlush, Noa Chapal-Ilani, Rivka Adar, et al.
Pediatric Blood & Cancer|November 7, 2015
Constitutional Mismatch Repair Deficiency in Israel: High Proportion of Founder Mutations in MMR Genes and ConsanguinityHagit N Baris, Inbal Barnes-Kedar, Helen Toledano, et al.
Blood|May 3, 2014
Novel activating mutations lacking cysteine in type I cytokine receptors in acute lymphoblastic leukemiaChen Shochat, Noa Tal, Vitalina Gryshkova, et al.
Blood|December 8, 2009
Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study GroupLibi Hertzberg, Elena Vendramini, Ithamar Ganmore, et al.
Pageof 7